Innovation
Best Device Concepts and Technological Trends Learning Series
Innovation in Aortic Valve Treatment
Episodes
Novel Management of TAVR Endocarditis: Antibiotic Releasing TAVR Valve
11 min.
Novel Vascular Closure Device for Large Bore Vascular Closures (xDot)
13 min.
Transcatheter Treatment of Chronic Aortic Regurgitation with the J-Valve TAVR System: EFS Results
11 min.
The JenaValve TAVR System: Lessons Learned from the Continued Access Study
14 min.
The INFLOW TAVR System: Polymeric and Biological Designs with a Unique Self-Positioning Delivery System
13 min.
SIEGEL TAVR: Technology Update and EFS Results (Mirus Medical)
10 min.
Novel Balloon-Expandable Transcatheter Heart Valve for Aortic Stenosis: Insights from the First-In-Human Series (Abbott)
12 min.
Expanding Valve Surgery Horizons with Personalized Leaflet Crafting: AvaTAR MedTech
11 min.
Keynote Lecture: From Big to Small and Back Again: Aligning Pediatric and Adult Structural Innovation
9 min.
Long-Term Outcomes After TAVR With a Self-Expanding Prosthesis
12 min.
Transcarotid Access for TAVR Using a Balloon Expandable Valve: Contemporary Results from a Real-World Registry
13 min.
What Is the Evidence for Clinical Surveillance in Severe Aortic Stenosis?
11 min.
Technology and Clinical Update: Aortic Capture and Removal Filters
17 min.
Updates from the Sentinel Clinical Trial Program: PROTECTED TAVR and BHF PROTECT-TAVI Meta-Analysis
13 min.
Untangling The Knot: Defining Appropriate Clinical Trial Endpoints and the Path Forward
11 min.
Technology and Clinical Update: Arch Deflector Devices
7 min.
Featured Research: A Prospective, Single-Arm, Multicenter Feasibility Trial to Evaluate the Safety and Performance of the F2 Filter and Delivery System Used for Embolic Protection During TAVR
13 min.
Advantages of Splitting Bicuspid Aortic Valve Leaflets Prior to TAVR: A New Paradigm for Leaflet Modification in BAV?
13 min.
BONAPART: A Novel Mechanical Leaflet Splitting Device
13 min.
The Evolution of Leaflet Modification Technologies: Emerging Techniques (e.g. UNICORN, BATMAN, etc), Technologies and Future Applications
8 min.
Debunking the Myths of Leaflet Modification: Evolution of Techniques, Systems and Clinical Applications
0
Is Aortic Regurgitation the Next Major TAVR Target?
19 min.
The NAVITOR Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities
6 min.
The EVOLUT Self-Expanding TAVR Program: Technology Focus and Clinical Trial Priorities
17 min.
The SAPIEN Balloon-Expandable TAVR Program: Technology Focus and Clinical Trial Priorities
16 min.
Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States
14 min.
New Design Features and Changing Clinical Topics for TAVR in the Next Decade!
13 min.
Biomimetic Design Restores Flow and Hemodynamics and Leads to Significant LV Mass Regression: Update From the First-In-Human (FIH) Study With the Novel DurAVR Transcatheter Heart Valve
12 min.
Next Generation Decision Support With AI-Based Predictive Modeling for Improved Long Term Outcomes (DASI Simulations)
8 min.
Aortic Valve Replacement Versus Clinical Surveillance in Moderate Aortic Stenosis With Reduced Ejection Fraction: Meta-Analysis of Reconstructed Time-to-Event Data
13 min.
First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR
12 min.
A Cutting-Edge Polyphenol-Based Coating Technology for the Third Generation of Polymer Heart Valves (BCI Technology)
8 min.
Innovation With a Novel Polymer Heart Valve (TRIA) Portfolio (FOLDAX)
13 min.
Transcatheter Aortic Valve Repair for Aortic Insufficiency Using the Cusper Device (Cuspa)
8 min.
Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)
14 min.
Valve Fracturing During Surgical Valve-in-Valve Procedures
19 min.
Access Disparities Affecting Appropriate AS Therapy
11 min.
Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program
6 min.
DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience
11 min.
Feasibility Study of a New Short, Self-Expanding TAVR Valve: Optimum TAV
11 min.
SIEGEL TAVR: A Revolutionary Ultra-Low Profile Aortic Valve Based Upon Rhenium Superalloys (Mirus)
11 min.
The Trilogy TAVR System (JenaValve) and an Update on the ALIGN-AR Study
12 min.
Dedicated TAVR Systems for AR - Technology and Program Updates: J-Valve
13 min.
Unsuccessful or Complicated Leaflet Modification in TAVR
19 min.
Leaflet Modification for TAV-in-TAV
5 min.
TELLTALE for TAV-in-SAV or TAV-in-Native
5 min.
BASILICA or ShortCut for TAV-in-SAVR or TAV-in-TAV
5 min.
Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting
16 min.
The 2024 'Toolbox' for Leaflet Modification in TAVR
6 min.
Can TAV-in-TAV Simulations be Useful in Procedural Planning?
11 min.
Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning
15 min.
Innovation in TAVR for Pure AR (J Valve)
13 min.
Aortic Stenosis - Lessons Learned in Highly Calcific Disease and Bicuspid Valves
11 min.
New Structural Innovation: What Is Next in the Pipeline From China
11 min.
Lifetime management of aortic stenosis
4 min.
The Lifetime Management of Aortic Stenosis: The Unmet Needs
49 min.
The Lifetime Management of Aortic Stenosis: A Heart Team Perspective
8 min.